GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ha Noi Pharma JSC (HSTC:DHN) » Definitions » Gross-Profit-to-Asset %

Ha Noi Pharma JSC (HSTC:DHN) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Ha Noi Pharma JSC Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Ha Noi Pharma JSC's annualized Gross Profit for the quarter that ended in . 20 was ₫ Mil. Ha Noi Pharma JSC's average Total Assets over the quarter that ended in . 20 was ₫ 0 Mil. Therefore, Ha Noi Pharma JSC's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.


Ha Noi Pharma JSC Gross-Profit-to-Asset % Historical Data

The historical data trend for Ha Noi Pharma JSC's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ha Noi Pharma JSC Gross-Profit-to-Asset % Chart

Ha Noi Pharma JSC Annual Data
Trend
Gross-Profit-to-Asset %

Ha Noi Pharma JSC Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of Ha Noi Pharma JSC's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Ha Noi Pharma JSC's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ha Noi Pharma JSC's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ha Noi Pharma JSC's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Ha Noi Pharma JSC's Gross-Profit-to-Asset % falls into.



Ha Noi Pharma JSC Gross-Profit-to-Asset % Calculation

Ha Noi Pharma JSC's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Ha Noi Pharma JSC's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Ha Noi Pharma JSC Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Ha Noi Pharma JSC's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ha Noi Pharma JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
170 La Thanh, O cho Dua ward, Dong Da district, Ha Noi city, VNM
Ha Noi Pharma JSC is engaged in the producing, trading, and importing of drugs. Some of its products are Bratorex, Polytincol, Gentamicin, and others.

Ha Noi Pharma JSC Headlines

No Headlines